好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Posterior Reversible Encephalopathy Syndrome (PRES) Secondary to Use of Axitinib in Renal Cell Cancer
General Neurology
P4 - (-)
012
Authors/Disclosures
Amin Sanei Moghaddam, MD (ProMedica)
PRESENTER
Dr. Sanei Moghaddam has nothing to disclose.
Guru Ramaiah, MD No disclosure on file
Mouhammad A. Jumaa, MD (ProMedica Stroke Network) Dr. Jumaa has nothing to disclose.
Syed F. Zaidi, MD (ProMedica Stroke Network) Dr. Zaidi has nothing to disclose.